病毒学
生物
牛痘
免疫系统
改良安卡拉痘苗
dna疫苗
细胞免疫
免疫学
佐剂
病毒载体
猿猴免疫缺陷病毒
重组DNA
免疫
生物化学
基因
作者
Antonio Valentin,Katherine McKinnon,Jinyao Li,Margherita Rosati,Viraj Kulkarni,Guy R. Pilkington,Jenifer Bear,Candido Alicea,Diego A. Vargas‐Inchaustegui,L. Jean Patterson,Poonam Pegu,Namal P. M. Liyanage,Shari N. Gordon,Monica Vaccari,Yichuan Wang,Alison Hogg,Blake Frey,Yongjun Sui,Steven G. Reed,Niranjan Y. Sardesai
标识
DOI:10.1016/j.clim.2014.09.005
摘要
To identify the most promising vaccine candidates for combinatorial strategies, we compared five SIV vaccine platforms including recombinant canary pox virus ALVAC, replication-competent adenovirus type 5 host range mutant RepAd, DNA, modified vaccinia Ankara (MVA), peptides and protein in distinct combinations. Three regimens used viral vectors (prime or boost) and two regimens used plasmid DNA. Analysis at necropsy showed that the DNA-based vaccine regimens elicited significantly higher cellular responses against Gag and Env than any of the other vaccine platforms. The T cell responses induced by most vaccine regimens disseminated systemically into secondary lymphoid tissues (lymph nodes, spleen) and effector anatomical sites (including liver, vaginal tissue), indicative of their role in viral containment at the portal of entry. The cellular and reported humoral immune response data suggest that combination of DNA and viral vectors elicits a balanced immunity with strong and durable responses able to disseminate into relevant mucosal sites.
科研通智能强力驱动
Strongly Powered by AbleSci AI